2019
DOI: 10.1158/1078-0432.ccr-18-3378
|View full text |Cite
|
Sign up to set email alerts
|

Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers

Abstract: Purpose: We aimed to develop an ovarian cancer-specific predictive framework for clinical stage, histotype, residual tumor burden, and prognosis using machine learning methods based on multiple biomarkers.Experimental Design: Overall, 334 patients with epithelial ovarian cancer (EOC) and 101 patients with benign ovarian tumors were randomly assigned to "training" and "test" cohorts. Seven supervised machine learning classifiers, including Gradient Boosting Machine (GBM), Support Vector Machine, Random Forest (… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
82
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 128 publications
(82 citation statements)
references
References 30 publications
(26 reference statements)
0
82
0
Order By: Relevance
“…Other studies used an ordinal classification method to predict surgical outcomes in aEOC patients with a 64.9% accuracy and AUC of 0.697 (R0 vs non-R0) based solely on preoperative information [19]. Another AI model predicted the outcome of surgery and again showed that ANN could predict outcome (optimal cytoreduction vs. suboptimal cytoreduction) with 77% accuracy and an AUC of 0.73.…”
Section: Discussionmentioning
confidence: 99%
“…Other studies used an ordinal classification method to predict surgical outcomes in aEOC patients with a 64.9% accuracy and AUC of 0.697 (R0 vs non-R0) based solely on preoperative information [19]. Another AI model predicted the outcome of surgery and again showed that ANN could predict outcome (optimal cytoreduction vs. suboptimal cytoreduction) with 77% accuracy and an AUC of 0.73.…”
Section: Discussionmentioning
confidence: 99%
“…1,2 Although a great deal of effort has been devoted to the study of new cytotoxic and targeted drugs and surgery, the overall survival rate of patients is still around 40%. 3,4 Standard treatment is still surgery, paclitaxel, carboplatin and combined chemotherapy, but recurrence and metastasis were happened in about 80% of patients. 5,6 As a result, it is crucial to discover significant biomarkers and to know their cellular and molecular mechanism in regulating the invasion and metastasis of ovarian cancer.…”
Section: Introductionmentioning
confidence: 99%
“…Serological diagnosis has always been a common method for malignant tumor patients, especially for ovarian cancer (OC) patients. Kawakami et al 34 have established a specific predictive framework for pretreatment estimation of histotypes, clinical stage, residual tumor burden and prognosis of epithelial ovarian cancer (EOC) patients using machine learning algorithms based on multiple biomarkers and clinical variables. They randomly assigned 334 patients with EOC and 101 patients with benign ovarian tumor into training group and testing group.…”
Section: Serological Diagnosismentioning
confidence: 99%